Association of tissue promoter methylation levels of APC, TGFβ2, HOXD3 and RASSF1A with prostate cancer progression. - Wikidata - wikimedia - TriplyDB

Association of tissue promoter methylation levels of APC, TGFβ2, HOXD3 and RASSF1A with prostate cancer progression.

Association of tissue promoter methylation levels of APC, TGFβ2, HOXD3 and RASSF1A with prostate cancer progression.

http://www.wikidata.org/entity/Q44284047

about

Epigenetic effects of green tea polyphenols in cancer Impact of glutathione-S-transferases (GST) polymorphisms and hypermethylation of relevant genes on risk of prostate cancer biochemical recurrence: a meta-analysis Validation study of genes with hypermethylated promoter regions associated with prostate cancer recurrence.DNA methylation gene-based models indicating independent poor outcome in prostate cancer.Methylation of APC and GSTP1 in non-neoplastic tissue adjacent to prostate tumour and mortality from prostate cancer.GSTP1 promoter methylation is associated with recurrence in early stage prostate cancer.RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes.Clinical utility of RASSF1A methylation in human malignancies.Epigenetic regulation of prostate cancer DNA hypomethylation affects cancer-related biological functions and genes relevant in neuroblastoma pathogenesis.Quantitative DNA methylation analysis of genes coding for kallikrein-related peptidases 6 and 10 as biomarkers for prostate cancer.Strategies for discovery and validation of methylated and hydroxymethylated DNA biomarkers.Prostate cancer: the need for biomarkers and new therapeutic targets.Aberrant DNA methylation of G-protein-coupled bile acid receptor Gpbar1 (TGR5) is a potential biomarker for hepatitis B Virus associated hepatocellular carcinoma.Novel multiplex MethyLight protocol for detection of DNA methylation in patient tissues and bodily fluids.Wnt and SHH in prostate cancer: trouble mongers occupy the TRAIL towards apoptosis.Diagnostic and prognostic molecular biomarkers for prostate cancer.APC gene hypermethylation and prostate cancer: a systematic review and meta-analysis.Methylation markers for prostate cancer prognosis: a systematic review.Prognostic DNA methylation markers for prostate cancer.The potential of DNA modifications as biomarkers and therapeutic targets in oncology.Promoter CpG-Site Methylation of the KAI1 Metastasis Suppressor Gene Contributes to Its Epigenetic Repression in Prostate Cancer.Promoter hypermethylation of tumor suppressor genes correlates with tumor grade and invasiveness in patients with urothelial bladder cancer.Methylation of PITX2, HOXD3, RASSF1 and TDRD1 predicts biochemical recurrence in high-risk prostate cancer.Comparative effects of soy phytoestrogens and 17β-estradiol on DNA methylation of a panel of 24 genes in prostate cancer cell lines.Control of epigenetic states by WT1 via regulation of de novo DNA methyltransferase 3A.DNA methylation profiling reveals novel biomarkers and important roles for DNA methyltransferases in prostate cancer.A cancer specific hypermethylation signature of the TERT promoter predicts biochemical relapse in prostate cancer: a retrospective cohort study.LINE-1 methylation status in prostate cancer and non-neoplastic tissue adjacent to tumor in association with mortality.DNA methylation screening of primary prostate tumors identifies SRD5A2 and CYP11A1 as candidate markers for assessing risk of biochemical recurrence.Distinct DNA methylation alterations are associated with cribriform architecture and intraductal carcinoma in Gleason pattern 4 prostate tumors.TGFB2 and BCL2L11 methylation in male laryngeal cancer patients Correlation of HOXD3 promoter hypermethylation with clinical and pathologic features in screening prostate biopsies.Frequent DNA Hypermethylation at the RASSF1A and APC Gene Loci in Prostate Cancer Patients of Pakistani Origin.DNA methylome and the complexity of discovering prostate cancer biomarkers.Integrated analysis of epigenomic and genomic changes by DNA methylation dependent mechanisms provides potential novel biomarkers for prostate cancer.APC methylation predicts biochemical recurrence of patients with prostate cancer: a meta-analysis.The association between RASSF1A promoter methylation and prostate cancer: evidence from 19 published studies.HOXA9, ISL1 and ALDH1A3 methylation patterns as prognostic markers for nonmuscle invasive bladder cancer: array-based DNA methylation and expression profiling.Epigenetic biomarkers: Current strategies and future challenges for their use in the clinical laboratory.

P2860

Q24568216-925F1C77-81F7-42B3-ABC5-E0B068F8B5A8 Q28533760-8EB7A40F-DF70-4BFF-A9D0-343C1E1A75C7 Q30582750-E372505B-3980-491D-AEAF-8E0B4C1E896F Q34174356-B2B56AF6-B7BD-40BD-B82C-FC8B00052AAC Q34847101-1EF0589A-6B32-4C86-98F1-9E9C80CD52DA Q35322421-A4F8D94F-0EBF-44BA-ABD1-C377F35C5049 Q35891000-6FEA8A11-D3FF-4631-8B60-CD8F7429EE75 Q35909621-F18762CD-53E3-48A8-96E3-71713893F11C Q36001910-03A2E543-6FF7-4CC2-8D8D-BAA440665A19 Q36380887-EDB2A8F3-C6C4-4CF6-AFC9-379B3CA223E4 Q36447329-A4D88BDF-ABFD-4543-A9AF-4DBA4A5E8D8A Q36530688-1938AB3C-A5A1-44E8-A5D6-6A314748C96E Q37476043-1ED18335-C372-4990-AE91-5F3B26A3079D Q37488688-172E9899-AAF4-40C7-8C7A-E3D370C87B1A Q37653469-7B8AA7C6-89E4-40A4-B9F9-90A9F3D7C967 Q37942610-4D7F4DE7-B506-4249-AC74-F56D02178294 Q37972703-82DBE821-EAF9-4448-A4E9-208F8C383599 Q38072660-173EE3B3-18B3-4557-A4B1-A053252C13E6 Q38116745-01DEE194-B964-40C1-9295-4A0417314668 Q38252624-77C62463-9D0D-4575-BACF-B29C6344AAA9 Q38591064-A4FE851A-FF4F-4B55-BBC2-AD0C7DA05D1A Q38733030-C17F796C-B683-4601-99FE-AAC974181195 Q38981120-53CF3EB5-1A42-44BA-AE1D-3E04825A3C62 Q38983831-A4F1C280-E44F-4FB9-AC1E-6A99C62ABEB0 Q39014316-6F34A8DD-7066-45DF-9C67-69F0C2123EDD Q39264413-25C26822-6E8E-4B5C-AF2A-0BF806B35EB5 Q39552467-EDE16572-B43E-4E0D-A06E-EED3700B2097 Q39581362-9EE112A2-554B-47AB-AD45-3E44476642A2 Q40454546-7F09C31C-E8AA-4EC3-A3A3-63F537D0ED9E Q40581966-0517B589-DA3A-4981-9F38-5E6916F7E1AD Q40977912-BD453F66-07BE-4FF2-8231-B2965C52C671 Q41195778-5CD107D4-86BF-485B-BB1E-4E5AAEB0C578 Q41767078-C60F4522-6EDE-4737-8AD0-E56D29D4928B Q41845384-14D13E89-C3AB-4F05-9CA7-0F318BF0DF38 Q42140874-65F24606-990C-42A8-856F-6C81064919A7 Q42950544-758E7D30-D5CA-49C8-B7BA-D243FAB0EE28 Q43156796-0313C8FD-CD31-4A6D-B682-7579BEDE9DD1 Q44538170-C905A9FC-6C10-4EC1-A859-A1D202388D20 Q45716446-FE2EBCB5-88A6-48C2-A22A-430A02E9F9D2 Q47789662-7608567D-28D7-47B0-BF5D-483BB8384448

P2860

Association of tissue promoter methylation levels of APC, TGFβ2, HOXD3 and RASSF1A with prostate cancer progression.

http://www.wikidata.org/entity/Q44284047

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Association of tissue promoter ...... h prostate cancer progression.

@en

Association of tissue promoter ...... h prostate cancer progression.

@nl

type

label

Association of tissue promoter ...... h prostate cancer progression.

@en

Association of tissue promoter ...... h prostate cancer progression.

@nl

prefLabel

Association of tissue promoter ...... h prostate cancer progression.

@en

Association of tissue promoter ...... h prostate cancer progression.

@nl

P1433

Q44284047-AB1CCDD9-1118-41E9-8EC1-AF2E9E230B60

P1476

Q44284047-14679CB8-F8BD-4C7F-90A7-584E65AB41C8

P2093

Q44284047-36298089-6482-44A9-AB55-DFB8B8B06FB8

Q44284047-4F015491-092A-451D-B694-E335F35FFF87

Q44284047-7D8C4CBC-B0D8-46B9-8F2A-AF8F7E708A3E

Q44284047-7FE20CA4-5056-491F-9818-2AEBD3BE864A

Q44284047-869CF027-C99B-4DD5-A044-4243E6BE8704

Q44284047-8DABA706-1455-47A1-A73D-C86014BE6219

Q44284047-97486F7E-352E-4560-86B3-80B3BDAC4F7B

Q44284047-BADB556B-5FC6-4C7A-A0DC-53CA5BBAF747

Q44284047-E2ACE4BB-CB06-4762-90A0-9495518CAD36

Q44284047-EEE7F4D8-3768-4861-9130-ED5BBEBF5FDF

P2860

Q44284047-09BD1C4C-5294-4498-B06F-815E140A726A

Q44284047-12FD55FD-477B-46A8-B83C-EA365462F4DB

Q44284047-178006EC-2D1D-4B84-BFFF-350F5D058E3F

Q44284047-3216CA74-578B-454C-87AD-966BCD01B20A

Q44284047-63036C0B-4B71-492A-BC68-16EA1D3D8BF2

Q44284047-6497432A-1DBE-4399-A735-57CBB5F10AE8

Q44284047-73C590A0-AB75-432D-82C9-D810BAB4CFDA

Q44284047-74637B54-5A26-43C0-8052-6776A2418099

Q44284047-7C803CFB-126F-426A-944A-7EDA5EF49081

Q44284047-891942A9-A623-4ED8-8528-2B370D3A0948

P304

Q44284047-238FB6AE-5A60-4F27-8BB8-44C6B7BB7EC5

P31

Q44284047-DEE82B59-93A3-4B7F-90B3-09A625007160

P356

Q44284047-79317B7C-663F-41F3-B5C1-4D11F767F3DE

P433

Q44284047-1BE48D92-27BD-4D89-8185-5AA36B6EA0E5

P478

Q44284047-09DEC970-2343-4D90-A820-F6CEC44D306F

P50

Q44284047-785C6185-8C45-4F24-A9DB-197C4C7AB2F9

P577

Q44284047-F57C8F05-0130-45E0-B626-9594833B8AA7

P5875

Q44284047-6A4EE731-D64D-428E-B781-5955F36EEA72

P698

Q44284047-ADFC4B98-51E0-4507-B5DA-DBF94442696D

P356

P1433

International Journal of Cancer

P1476

Association of tissue promoter ...... h prostate cancer progression.

@en

P2093

Bharati Bapat

http://www.w3.org/2001/XMLSchema#string

Hilmi Ozcelik

http://www.w3.org/2001/XMLSchema#string

John Trachtenberg

http://www.w3.org/2001/XMLSchema#string

Ken J Kron

http://www.w3.org/2001/XMLSchema#string

Laurent Briollais

http://www.w3.org/2001/XMLSchema#string

Liyang Liu

http://www.w3.org/2001/XMLSchema#string

Michael E Nesbitt

http://www.w3.org/2001/XMLSchema#string

Neil E Fleshner

http://www.w3.org/2001/XMLSchema#string

Nino Demetrashvili

http://www.w3.org/2001/XMLSchema#string

Vaijayanti V Pethe

http://www.w3.org/2001/XMLSchema#string

P2860

Discovery of novel hypermethylated genes in prostate cancer using genomic CpG island microarrays

MethyLight: a high-throughput assay to measure DNA methylation

Cancer statistics, 2009

Discrepancy between Gleason scores of biopsy and radical prostatectomy specimens.

Epigenetic changes in prostate cancer: implication for diagnosis and treatment.

Methylation of the RASSF1A gene in human cancers.

The use of PCA3 in the diagnosis of prostate cancer.

Role of the Ras-association domain family 1 tumor suppressor gene in human cancers.

Roles and regulation of Wnt signaling and beta-catenin in prostate cancer.

P304

2454-2462

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.25908

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

129

http://www.w3.org/2001/XMLSchema#string

P50

Theodorus H Van der Kwast

P577

2011-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49729974

http://www.w3.org/2001/XMLSchema#string

P698

21207416

http://www.w3.org/2001/XMLSchema#string